Cargando…
Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection
BACKGROUND: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is clinically defined and characterised by persistent disabling tiredness and exertional malaise, leading to functional impairment. METHODS: This study introduces the weighted standing time (WST) as a proxy for ME/CFS severity,...
Autores principales: | Richardson, Alice M., Lewis, Don P., Kita, Badia, Ludlow, Helen, Groome, Nigel P., Hedger, Mark P., de Kretser, David M., Lidbury, Brett A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898049/ https://www.ncbi.nlm.nih.gov/pubmed/29650052 http://dx.doi.org/10.1186/s12967-018-1473-z |
Ejemplares similares
-
Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
por: Lidbury, Brett A., et al.
Publicado: (2017) -
Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity
por: Lidbury, Brett A., et al.
Publicado: (2019) -
Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS
por: Morrow, Amanda K., et al.
Publicado: (2022) -
Deconditioning does not explain orthostatic intolerance in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome)
por: van Campen, C. (Linda) M. C., et al.
Publicado: (2021) -
Biomedical Insights That Inform the Diagnosis of ME/CFS
por: Lidbury, Brett A., et al.
Publicado: (2020)